Market revenue in 2023 | USD 59.9 million |
Market revenue in 2030 | USD 100.0 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Fish |
Fastest growing segment | CISH |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | FISH, CISH |
Key market players worldwide | Thermo Fisher Scientific Inc, Abbott Laboratories, Agilent Technologies Inc, Merck KGaA, Bio-Rad Laboratories Inc, Bio View Ltd, Revvity Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in situ hybridization market will help companies and investors design strategic landscapes.
Fish was the largest segment with a revenue share of 53.42% in 2023. Horizon Databook has segmented the Canada in situ hybridization market based on fish, cish covering the revenue growth of each sub-segment from 2018 to 2030.
Various local market players have deployed different strategies to sustain their position in the competitive environment. For instance, Vector Laboratories, headquartered in Canada, has over 40 distributors globally. The company also promotes awareness about its advanced technologies by releasing whitepapers to enhance product uptake.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada in situ hybridization market , including forecasts for subscribers. This country databook contains high-level insights into Canada in situ hybridization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account